Literature DB >> 18539663

Results of the Birmingham Hip Resurfacing dysplasia component in severe acetabular insufficiency: a six- to 9.6-year follow-up.

D J W McMinn1, J Daniel, H Ziaee, C Pradhan.   

Abstract

The dysplasia cup, which was devised as an adjunct to the Birmingham Hip Resurfacing system, has a hydroxyapatite-coated porous surface and two supplementary neutralisation screws to provide stable primary fixation, permit early weight-bearing, and allow incorporation of morcellised autograft without the need for structural bone grafting. A total of 110 consecutive dysplasia resurfacing arthroplasties in 103 patients (55 men and 48 women) performed between 1997 and 2000 was reviewed with a minimum follow-up of six years. The mean age at operation was 47.2 years (21 to 62) and 104 hips (94%) were Crowe grade II or III. During the mean follow-up of 7.8 years (6 to 9.6), three hips (2.7%) were converted to a total hip replacement at a mean of 3.9 years (2 months to 8.1 years), giving a cumulative survival of 95.2% at nine years (95% confidence interval 89 to 100). The revisions were due to a fracture of the femoral neck, a collapse of the femoral head and a deep infection. There was no aseptic loosening or osteolysis of the acetabular component associated with either of the revisions performed for failure of the femoral component. No patient is awaiting a revision. The median Oxford hip score in 98 patients with surviving hips at the final review was 13 and the 10th and the 90th percentiles were 12 and 23, respectively.

Entities:  

Mesh:

Year:  2008        PMID: 18539663     DOI: 10.1302/0301-620X.90B6.19875

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  9 in total

1.  Revision rate of Birmingham Hip Resurfacing arthroplasty: comparison of published literature and arthroplasty register data.

Authors:  Reinhard Schuh; Daniel Neumann; Rauend Rauf; Jochen Hofstaetter; Nikolaus Boehler; Gerold Labek
Journal:  Int Orthop       Date:  2012-02-22       Impact factor: 3.075

2.  Survivorship and clinical outcome of Birmingham hip resurfacing: a minimum ten years' follow-up.

Authors:  Md Quamar Azam; Stephen McMahon; Gabrielle Hawdon; Sukesh Rao Sankineani
Journal:  Int Orthop       Date:  2015-03-31       Impact factor: 3.075

3.  Prevalence of dysplasia as the source of worse outcome in young female patients after hip resurfacing arthroplasty.

Authors:  Thomas P Gross; Fei Liu
Journal:  Int Orthop       Date:  2011-06-07       Impact factor: 3.075

4.  [Periprosthetic intertrochanteric fracture of the femur following articular resurfacing of the hip joint: treatment with lag screw osteosynthesis].

Authors:  T Lein; J Schlee; M Kothe; F Moritz; D T Wubtaye
Journal:  Unfallchirurg       Date:  2010-11       Impact factor: 1.000

5.  Frank Stinchfield Award: Identification of the At-risk Genotype for Development of Pseudotumors Around Metal-on-metal THAs.

Authors:  Brett K J Kilb; Andrew P Kurmis; Michael Parry; Karen Sherwood; Paul Keown; Bassam A Masri; Clive P Duncan; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

6.  The natural history of inflammatory pseudotumors in asymptomatic patients after metal-on-metal hip arthroplasty.

Authors:  Sulaiman A Almousa; Nelson V Greidanus; Bassam A Masri; Clive P Duncan; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

7.  Poor outcome of revised resurfacing hip arthroplasty.

Authors:  Richard N de Steiger; Lisa N Miller; Gareth H Prosser; Stephen E Graves; David C Davidson; Tyman E Stanford
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

8.  Deformation of the Durom acetabular component and its impact on tribology in a cadaveric model--a simulator study.

Authors:  Feng Liu; Zhefeng Chen; Yanqing Gu; Qing Wang; Weiding Cui; Weimin Fan
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

9.  Early catastrophic failure of Birmingham acetabular dysplasia cup in revision arthroplasty: a case report.

Authors:  Manjunath Ramappa; Andrew Port
Journal:  Cases J       Date:  2009-07-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.